Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Charles S. Abrams, MD
Healthcare Provider Francis C. Wood Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
812 BRB II/III
421 Curie Blvd.
Philadelphia, Pennsylvania, United States
Dr. Abrams is Francis C. Wood Professor of medicine, pathology, and laboratory medicine, as well as director of the Blood Center for Patient Care and Discovery at the University of Pennsylvania and Children’s Hospital of Philadelphia. He is the Vice Chair for Research and Chief Scientific Officer of the Department of Medicine at the University of Pennsylvania. His clinical and research interests have focused on the role of platelets in bleeding and clotting disorders, inflammation, and metastasis formation.
Dr. Abrams is also the principal investigator of a National Institutes of Health (NIH) Program Project Grant and a K12 mentored training grant. Dr. Abrams has been elected to the American Society of Clinical Investigation and the Association of American Physicians. He was the 2016 ASH President. Dr. Abrams received his medical degree from Yale University School of Medicine. After an internship at Temple University Hospital, Dr. Abrams completed a residency and hematology-oncology fellowship at the Hospital of the University of Pennsylvania.
+myBinderRelated Content
-
Trends in Sickle Cell Disease-related Priapism in U.S. Children’s HospitalsOBJECTIVE: To define rates of priapism ...
-
Emergency Guide: When to see the doctorIt is very important that every person o...
-
Marsha Treadwell, PhDMarsha J. Treadwell, PhD, is a clinical ...
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
-
Pierrette (P) Mimi Poinsett, MDDr. Pierrette Mimi Poinsett is a physici...
-
Why do blood types matter? – Natalie S. Hodgehttps://www.youtube.com/watch?v=xfZhb6lm...
-
Global Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...
